[1]JournalofMedicinalChemistry,2010,vol.53,#3,p.1357-1369
[2]BollettinoScientificodellaFacoltadiChimicaIndustrialediBologna,1953,vol.11,p.42
[1]BioorganicandMedicinalChemistryLetters,2014,vol.24,#4,p.1218-1221
[1]JournalofChemicalSciences,2017,vol.129,#2,p.141-148
[2]JournaloftheChemicalSociety,PerkinTransactions1:OrganicandBio-OrganicChemistry(1972-1999),1982,p.357-364
[3]OrganicMagneticResonance,1980,vol.14,#4,p.300-304
[1]BulletindesSocietesChimiquesBelges,1986,vol.95,#8,p.663-670
[2]JournaloftheChemicalSociety,1953,p.2816,2819
[1]BollettinoScientificodellaFacoltadiChimicaIndustrialediBologna,1958,vol.16,p.1
[1]Chemistry-AEuropeanJournal,2012,vol.18,p.9552-9563
[2]AngewandteChemie-InternationalEdition,2019,vol.58,p.6911-6915 Angew.Chem.,2019,vol.131,p.6985-6989,5
[3]ChemistryofHeterocyclicCompounds,1968,vol.4,p.75-77 KhimiyaGeterotsiklicheskikhSoedinenii,1968,vol.4,p.95-98
[1]ChemicalandPharmaceuticalBulletin,1982,vol.30,p.2996-3004
[1]JournalofChemicalSciences,2017,vol.129,p.141-148
[2]JournaloftheChemicalSociety.PerkintransactionsI,1982,p.357-364
[3]OrganicMagneticResonance,1980,vol.14,p.300-304
[1]CarbohydrateResearch,1981,vol.90,p.144-148
[1]CarbohydrateResearch,1981,vol.90,p.144-148
Title: One scaffold, three binding modes: novel and selective pteridine reductase 1 inhibitors derived from fragment hits discovered by virtual screening.
Journal: Journal of medicinal chemistry 20090723